163 related articles for article (PubMed ID: 19671824)
41. Bisphosphonate-related osteonecrosis of the jaw around dental implants in the maxilla: report of a case.
Shirota T; Nakamura A; Matsui Y; Hatori M; Nakamura M; Shintani S
Clin Oral Implants Res; 2009 Dec; 20(12):1402-8. PubMed ID: 19793318
[TBL] [Abstract][Full Text] [Related]
42. Osteonecrosis of the jaw in a patient treated with ibandronate.
Vomvas D; Vassiliou V; Papavasileiou D; Kalogeropoulou C; Nicolatou-Galitis O; Kardamakis D
J BUON; 2008; 13(3):441-2. PubMed ID: 18979566
[No Abstract] [Full Text] [Related]
43. Bisphosphonates, as a new cause of drug-induced jaw osteonecrosis: an update.
Jimenez-Soriano Y; Bagan JV
Med Oral Patol Oral Cir Bucal; 2005 Jul; 10 Suppl 2():E88-91. PubMed ID: 15995577
[No Abstract] [Full Text] [Related]
44. Bisphosphonates, phossy jaw, and bisphosphonate-related osteonecrosis of the jaw.
Lewis DM
J Okla Dent Assoc; 2011; 102(5):36-9. PubMed ID: 21874699
[No Abstract] [Full Text] [Related]
45. Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series.
Fedele S; Porter SR; D'Aiuto F; Aljohani S; Vescovi P; Manfredi M; Arduino PG; Broccoletti R; Musciotto A; Di Fede O; Lazarovici TS; Campisi G; Yarom N
Am J Med; 2010 Nov; 123(11):1060-4. PubMed ID: 20851366
[TBL] [Abstract][Full Text] [Related]
46. [Osteonecrosis of the jaw].
Eriksen EF
Ugeskr Laeger; 2009 Feb; 171(8):629; author reply 629. PubMed ID: 19291862
[No Abstract] [Full Text] [Related]
47. Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma.
Diego R; D'Orto O; Pagani D; Agazzi A; Marzano U; Derada Troletti G; Fontanella W; Pignataro L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e1-5. PubMed ID: 17197204
[TBL] [Abstract][Full Text] [Related]
48. Osteonecrosis of the jaw & osteoporosis therapy.
Kessenich CR
Nurse Pract; 2010 Jul; 35(7):51-3. PubMed ID: 20555246
[No Abstract] [Full Text] [Related]
49. Osteonecrosis of the jaws caused by bisphosphonates: evaluation of a new therapeutic approach using the Er:YAG laser.
Angiero F; Sannino C; Borloni R; Crippa R; Benedicenti S; Romanos GE
Lasers Med Sci; 2009 Nov; 24(6):849-56. PubMed ID: 19277823
[TBL] [Abstract][Full Text] [Related]
50. Bisphosphonate-related osteonecrosis of the jaw.
Feller L; Wood NH; Khammissa RA; Chikte UM; Bouckaert M; Lemmer J
SADJ; 2011 Feb; 66(1):30-2. PubMed ID: 21510174
[TBL] [Abstract][Full Text] [Related]
51. Osteonecrosis of the jaw after oral bisphosphonate for osteoporosis.
Tong CK; Ho ST; Wong SL
Hong Kong Med J; 2010 Apr; 16(2):145-8. PubMed ID: 20354251
[TBL] [Abstract][Full Text] [Related]
52. Intravenous bisphosphonate-associated osteonecrosis of the jaw.
Statz TA; Guthmiller JM; Humbert LA; Johnson GK
J Periodontol; 2007 Nov; 78(11):2203-8. PubMed ID: 17970689
[TBL] [Abstract][Full Text] [Related]
53. Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis.
Manfredi M; Merigo E; Guidotti R; Meleti M; Vescovi P
Int J Oral Maxillofac Surg; 2011 Mar; 40(3):277-84. PubMed ID: 21163625
[TBL] [Abstract][Full Text] [Related]
54. Primary surgical therapy for osteonecrosis of the jaw secondary to bisphosphonate therapy.
Kademani D; Koka S; Lacy MQ; Rajkumar SV
Mayo Clin Proc; 2006 Aug; 81(8):1100-3. PubMed ID: 16901034
[TBL] [Abstract][Full Text] [Related]
55. Osteonecrosis of the jaw.
Sykes DL
Dent Today; 2007 Feb; 26(2):16. PubMed ID: 17348272
[No Abstract] [Full Text] [Related]
56. [Bisphosphonate-related osteonecrosis of the jaw].
Franken AA; van Blijderveen NJ; Witjes MJ; Netelenbos CJ
Ned Tijdschr Geneeskd; 2011; 155():A3077. PubMed ID: 21486510
[TBL] [Abstract][Full Text] [Related]
57. Osteonecrosis of the jaw after treatment with bisphosphonates: is irreversible, so the focus must be on prevention.
Landis BN; Richter M; Dojcinovic I; Hugentobler M
BMJ; 2006 Nov; 333(7576):982-3. PubMed ID: 17095762
[No Abstract] [Full Text] [Related]
58. Bisphosphonate-induced osteonecrosis of the jaw: long-term outcomes.
Katz J; George T; Sandow P; Machado M; Dickerson L; Moreb JS
J Support Oncol; 2009; 7(1):9-10. PubMed ID: 19278171
[No Abstract] [Full Text] [Related]
59. Osteonecrosis of the jaw and the use of antiangiogenic agents: just an association?
Aragon-Ching JB; Dahut WL
Oncologist; 2008 Dec; 13(12):1314; author reply 1315. PubMed ID: 19088325
[No Abstract] [Full Text] [Related]
60. Osteonecrosis of the jaws: maxillofacial recommendations for bisphosphonate prescribers.
Landis BN; Dojcinovic I; Richter M; Hugentobler M
J Intern Med; 2007 Jan; 261(1):101-2. PubMed ID: 17222173
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
